1-(3,4-Dimethoxyphenyl)ethanamine hydrochloride, 97%, 2.5g

Imatinib>98.0%(HPLC)100mg

Benzyl trifluoroacetate, 25g

4-Hydroxy-5-methoxy-2-nitrobenzoic acid, 97%, 250mg

2,3,4-Trichloropyridine, 95.0%, 5g

GC capillary column ROTI®Cap-1, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole, 97.0%, 1g

Methyl 3-Methyl-4-nitrobenzoate, 97.0%, 25g

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate, 95.0%, 100mg

2,2-Bis[(4S)-4-benzyl-2-oxazolin-2-yl]propane, 98.0%, 250mg

Ethyl 2-(pyridin-2-ylsulfanyl)acetate, 97.0%, 5g

2-Bromo-4-(trifluoromethoxy)iodobenzene, 99.0%, 100g

(3R,4R)-(3-HYDROXY-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 1g